Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis

Company Overview

Prestige Consumer Healthcare, Inc. is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health.

Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy). Prestige distributes its products primarily in the United States and Canada through supermarket, drug store, mass merchandise, dollar, club and e-commerce channels, and selectively in other markets through export partnerships.

Formed through a series of strategic acquisitions of established consumer healthcare names, Prestige Consumer Healthcare has grown by integrating well-known OTC brands under a centralized commercial and operational platform. The company is headquartered in Tarrytown, New York, and leverages a focused R&D and regulatory support team to drive incremental innovation across its brand portfolio. Tony Long has served as President and Chief Executive Officer since December 2019, leading initiatives to expand Prestige’s market presence and enhance its category leadership.

Key Stats

• Today's Range: $66.40 to $66.85
• 50-Day Range: $64.04 to $81.90
• 52-Week Range: $62.95 to $90.04
• Volume: 40,365 shs
• Average Volume: 398,993 shs
• Market Capitalization: $3.27 billion
• P/E Ratio: 15.62
• Dividend Yield: N/A
• Price Target: $93.33
• Consensus Rating: Moderate Buy

Prestige Consumer Healthcare Stock Analysis - MarketRank™

Prestige Consumer Healthcare scored higher than 96% of companies evaluated by MarketBeat, and ranked 86th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Prestige Consumer Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Prestige Consumer Healthcare has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 5.78%

Earnings Growth

Earnings for Prestige Consumer Healthcare are expected to grow by 5.78% in the coming year, from $4.50 to $4.76 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Prestige Consumer Healthcare is 15.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 269.37.

Price to Earnings Ratio vs. Sector

The P/E ratio of Prestige Consumer Healthcare is 15.61, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 83.22.

Price to Earnings Growth Ratio

Prestige Consumer Healthcare has a PEG Ratio of 2.15. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Prestige Consumer Healthcare has a P/B Ratio of 1.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.53% of the float of Prestige Consumer Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Prestige Consumer Healthcare has recently decreased by 5.38%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Prestige Consumer Healthcare does not currently pay a dividend.

Dividend Growth

Prestige Consumer Healthcare does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Prestige Consumer Healthcare is 44.60%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Prestige Consumer Healthcare will have a dividend payout ratio of 39.92% next year. This indicates that Prestige Consumer Healthcare will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.5 / 5
• Environmental Score: -2.35

Percentage of Shares Shorted

2.53% of the float of Prestige Consumer Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Prestige Consumer Healthcare has recently decreased by 5.38%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.99

News Sentiment

Prestige Consumer Healthcare has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 15 news articles for Prestige Consumer Healthcare this week, compared to 6 articles on an average week.

Search Interest

2 people have searched for PBH on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Prestige Consumer Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.40% of the stock of Prestige Consumer Healthcare is held by insiders.

Percentage Held by Institutions

99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PBH Stock Analysis - Frequently Asked Questions

How have PBH shares performed this year?

Prestige Consumer Healthcare's stock was trading at $78.09 at the beginning of 2025. Since then, PBH stock has decreased by 14.8% and is now trading at $66.50.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) announced its quarterly earnings results on Thursday, August, 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.01 by $0.06. Prestige Consumer Healthcare's quarterly revenue was down 6.6% compared to the same quarter last year.
Read the conference call transcript.

Who are Prestige Consumer Healthcare's major shareholders?

Top institutional shareholders of Prestige Consumer Healthcare include Ariel Investments LLC (4.48%), State Street Corp (4.06%), Allspring Global Investments Holdings LLC (3.08%) and Geode Capital Management LLC (2.86%). Insiders that own company stock include Ronald M Lombardi, William P'pool, Adel Mekhail and Mary Beth Fritz.
View institutional ownership trends.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AU Optronics (AUOTY).

Company Calendar

• Last Earnings: 8/07/2025
• Today: 9/03/2025
• Next Earnings (Estimated): 11/06/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Personal Products
• Current Symbol: NYSE:PBH
• CIK: 1295947
• Web: www.prestigebrands.com
• Phone: (914) 524-6800
• Fax: 302-674-5266
• Employees: 540
• Year Founded: 1996

Price Target and Rating

• Average Price Target for Prestige Consumer Healthcare: $93.33
• High Price Target: $104.00
• Low Price Target: $76.00
• Potential Upside/Downside: +40.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.26
• Trailing P/E Ratio: 15.61
• Forward P/E Ratio: 14.78
• P/E Growth: 2.15
• Net Income: $214.60 million
• Net Margins: 19.02%
• Pretax Margin: 25.67%
• Return on Equity: 12.69%
• Return on Assets: 6.79%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 4.38
• Quick Ratio: 2.99

Sales & Book Value

• Annual Sales: $1.12 billion
• Price / Sales: 2.92
• Cash Flow: $5.10 per share
• Price / Cash Flow: 13.05
• Book Value: $37.70 per share
• Price / Book: 1.76

Miscellaneous

• Outstanding Shares: 49,214,000
• Free Float: 48,525,000
• Market Cap: $3.27 billion
• Optionable: Optionable
• Beta: 0.46